Hollings Renton, Director at CEPHEID (CPHD), sold 12,500 shares at $41.44 ($518K) on 2013-11-08, disclosed to the SEC on 2013-11-13.
Open-market sale of $518k CPHD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |